Riskpilot← Back to searchSign inGet full accessTrackvent Pharmacy AB
ABActiveOrg 5593806077Köpsvängen 10Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20220 employees
Revenue 2024
SEK 80K
-8001800% vs 2023
EBITDA margin
-148.4%
-247% vs 2023
Equity ratio
-191.3%
Financial strength
Net profit 2024
SEK -119K
-2816% vs 2023
| Revenue | SEK 80K | -8001800% |
| EBITDA | SEK -119K | -247% |
| Net profit | SEK -119K | -2816% |
| Total assets | SEK 54K | +159% |
| Equity | SEK -103K | -765% |
| Employees | 0 | — |
Legal name
Trackvent Pharmacy AB
Org number
5593806077
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13 maj 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet ska vara handel med apoteksvaror, egenvårdsprodukter (OTC-läkemedel), läkemedel samt läkemedelsdistribution och därmed förenlig verksamhet.
Address
Köpsvängen 10
Email
leith.yassir@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | — | −0 | 80 |
| Staff expenses | — | −0 | — |
| EBITDA | −5 | −34 | −119 |
| Depreciation & amort. | — | — | — |
| EBIT | −5 | −34 | −119 |
| Net financials | 0 | 0 | 0 |
| Profit before tax | −5 | −4 | −119 |
| Tax | — | — | — |
| Net profit | −5 | −4 | −119 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 24 | 21 | 54 |
| Equity | 20 | 16 | −103 |
| Long-term debt | — | — | — |
| Short-term debt | 4 | 5 | 157 |
| Total debt | 4 | 5 | 157 |
EBITDA margin
-148.4%
This company
15.8%
Market median
-1039% vs market
20222024
Equity ratio
-191.3%
This company
38.2%
Market median
-601% vs market
20222024
Return on equity
-11875900.0%
This company
18.4%
Market median
-64543035% vs market
20222024
Net profit margin
-148.4%
This company
8.1%
Market median
-1932% vs market
20222024
Asset turnover
1.48×
This company
1.12×
Market median
+32% vs market
20222024
Debt / equity
1.52×
This company
0.62×
Market median
-145% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (3) | ||
| Deputy Board Member | 2024 – 2025 | |
| Deputy Board Member | 2022 – 2024 | |
| Deputy Board Member | 2024 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Trackvent Pharmacy AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leith Abdul Wahid Yassir | Chief Executive Officer | 0 companies |
| Said Esmaeil Mirza Hosseini | Deputy Board Member | 0 companies |
| Hamon Hosseini | Deputy Board Member | 0 companies |
| Lilas Yassir | Deputy Board Member | 0 companies |
| Artikas Antero Isa Hatunen | Deputy Board Member | 0 companies |